Dynatronics Co. (NASDAQ:DYNT) has earned an average rating of “Buy” from the six analysts that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $3.50.
Several analysts have issued reports on DYNT shares. ValuEngine cut Dynatronics from a “buy” rating to a “hold” rating in a research report on Wednesday. Zacks Investment Research cut Dynatronics from a “buy” rating to a “hold” rating in a research report on Tuesday. Finally, Maxim Group set a $3.00 target price on Dynatronics and gave the company a “buy” rating in a research report on Thursday, September 26th.
NASDAQ DYNT traded down $0.05 during midday trading on Thursday, hitting $0.99. 3,124 shares of the company traded hands, compared to its average volume of 170,232. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.36 and a quick ratio of 0.59. The company has a market cap of $9.63 million, a PE ratio of -4.52 and a beta of 0.07. The company’s 50-day simple moving average is $0.82 and its 200-day simple moving average is $1.12. Dynatronics has a 52 week low of $0.63 and a 52 week high of $2.79.
Dynatronics (NASDAQ:DYNT) last announced its earnings results on Tuesday, November 12th. The medical equipment provider reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $16.39 million for the quarter, compared to analysts’ expectations of $16.21 million. Dynatronics had a negative return on equity of 12.16% and a negative net margin of 1.84%. On average, research analysts predict that Dynatronics will post -0.13 earnings per share for the current year.
A hedge fund recently raised its stake in Dynatronics stock. Citadel Advisors LLC lifted its holdings in Dynatronics Co. (NASDAQ:DYNT) by 75.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,043 shares of the medical equipment provider’s stock after purchasing an additional 12,908 shares during the quarter. Citadel Advisors LLC owned about 0.36% of Dynatronics worth $50,000 as of its most recent SEC filing. Institutional investors and hedge funds own 11.70% of the company’s stock.
Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.
Featured Story: Stock Symbol
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.